Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease

As we learn more about genetics and disease, researchers are exploring ways to try to counteract the effects of certain disorders. A new Cochrane review from Peter Gøtzsche and Helle Krogh Johansen at the Nordic Cochrane Centre examines research into a genetic disorder called alpha-1 antitrypsin deficiency. Peter Gøtzsche describes their findings.